Tiago Girao
Equibles does not estimate personal net worth.
Get an email with a short summary when Immunovant, Inc. publishes a filing, an earnings call transcript or a press release.
Get IMVT alertsAbout Tiago Girao
Tiago Girao is recorded as CFO at Immunovant, Inc. (IMVT). The newest filing on record that lists Tiago Girao as CFO at Immunovant, Inc. (IMVT) is dated July 22, 2026. Immunovant, Inc. reported in an 8-K filed April 21, 2025 that Tiago Girao was appointed Chief Financial Officer (including the principal financial officer and principal accounting officer), effective April 21, 2025. The proxy statement of Immunovant, Inc. reports total compensation of $7,616,437 for Tiago Girao in fiscal 2026, including a base salary of $455,493. Immunovant, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunovant, Inc. includes Eric Venker (CEO), Eric Venker, M.D. (CEO and Board Member), Eric Venker, M.D., Pharm.D. (CEO) and 7 others.
“In addition, on April 18, 2025, upon the recommendation of the Nominating Committee, the Board appointed Tiago Girao as Chief Financial Officer (including the principal financial officer and principal accounting officer) of the Company, effective as of the Start Date.”
Affiliation history
-
Current
Start not stated–present
Last confirmed July 22, 2026
Company network
Leadership on record at Immunovant, Inc.
- Eric Venker CEO
- Eric Venker, M.D. CEO, Board Member
- Eric Venker, M.D., Pharm.D. CEO
- Dr. Frank M. Torti Chairman
- Renee Barnett CFO
- Melanie Gloria COO
- Jay S. Stout CTO
- W. Bradford Middlekauff General Counsel
- Andrew Fromkin Board Member
- Atul Pande, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Immunovant, Inc. (IMVT) | Chief Financial Officer | $455,493 | $7,616,437 |